Telehealth for opioid use disorder in vulnerable settings
Part of Mental health clinical trials.
This trial tests whether a telehealth program can help people with opioid use disorder get and stay on buprenorphine treatment. It aims to make care more accessible for those in vulnerable situations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a history of opioid use disorder.
- You are starting buprenorphine treatment now, or have started it within the past 45 days.
- You speak and understand English.
- You are not allergic to buprenorphine.
- You plan to stay in a Boulder Care-affiliated state for the next 12 months.
- You do not have any untreated mental or medical condition that would keep you from taking part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether telehealth can improve treatment for opioid use disorder and related mental health issues, especially for people who face barriers to care. It may help patients stay connected to their buprenorphine treatment from home.
This study tests whether treatment for opioid use disorder can be done effectively through telehealth (video calls and texts). It is designed for people who are not currently on medication for opioid addiction and want to start treatment from home.
This study compares follow-up care after an emergency department visit for opioid addiction: either through telehealth (video visits) or in-person appointments. The goal is to see which method helps people stay in treatment after they leave the ED.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This study tests a package of support services to help people who have had an opioid overdose and are starting buprenorphine in the emergency department. The goal is to keep them safe and reduce the chance of another overdose.
This study tests a new way to receive buprenorphine—a once-a-month injection—from a mobile clinic that comes to you. It aims to make treatment more convenient and acceptable for people with opioid use disorder.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.